Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Fluzone Quadrivalent vaccine, 2018-2019 formulation
Flublok Quadrivalent vaccine, 2018-2019 formulation
+1 more
Locations
3
United States
Investigational Site Number 8400003
Bardstown, Kentucky, United States
Investigational Site Number 8400001
Metairie, Louisiana, United States
Investigational Site Number 8400002
Salt Lake City, Utah, United States
Start Date
September 10, 2018
Primary Completion Date
November 12, 2018
Completion Date
November 12, 2018
Last Updated
March 29, 2022
NCT07291635
NCT06094010
NCT06417762
NCT06160128
NCT07396428
NCT07310472
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions